Onapristone ER
19-061
Phase 2 small_molecule completed
Quick answer
Onapristone ER for Granulosa Cell Ovarian Cancer is a Phase 2 program (small_molecule) at Context Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Context Therapeutics
- Indication
- Granulosa Cell Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed